keyword
https://read.qxmd.com/read/38621803/continuity-and-breaches-in-gp-care-and-their-associations-with-mortality-for-patients-with-chronic-disease-an-observational-study-using-norwegian-registry-data
#21
JOURNAL ARTICLE
Sahar Pahlavanyali, Øystein Hetlevik, Valborg Baste, Jesper Blinkenberg, Steinar Hunskaar
BACKGROUND: Despite many benefits of continuity of care with a named regular GP (RGP), continuity is deteriorating in many countries. AIM: To investigate the association between RGP continuity and mortality, in a personal list system, in addition to examining how breaches in continuity affect this association for patients with chronic diseases. DESIGN AND SETTING: A registry-based observational study using Norwegian primary care consultation data for patients with asthma, chronic obstructive pulmonary disease (COPD), diabetes mellitus, or heart failure...
April 15, 2024: British Journal of General Practice
https://read.qxmd.com/read/38618968/association-of-single-point-insulin-sensitivity-estimator-index-spise-with-future-cardiovascular-outcomes-in-patients-with-type-2-diabetes
#22
JOURNAL ARTICLE
Simin Deng, Xinqun Hu, Xiangyu Zhang
AIMS: To investigate the association of single-point insulin sensitivity estimator (SPISE) index with future cardiovascular outcomes in patients with type 2 diabetes. MATERIALS AND METHODS: SPISE index (= 600 × high-density lipoprotein cholesterol [mg/dL]0.185 /triglycerides [mg/dL]0.2  × body mass index [kg/m2 ]1.338 ) was calculated in 10 190 participants. Cox proportional hazard regression models were applied to evaluate the association between SPISE index and future cardiovascular outcomes...
April 15, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38617770/comparison-of-safety-and-effectiveness-of-different-sheaths-in-ablation-of-focal-atrial-tachycardia-a-retrospective-study
#23
JOURNAL ARTICLE
Min Xie, Dingming Liu, Ruikun Jia, Yixuan Bai, Juan Chan, Zhongyun Lin, Paul Khairy, Kaijun Cui
BACKGROUND: A novel visualized steerable sheath, referred to as the Vizigo sheath, has been utilized in clinical interventions. The objective of this study was to evaluate and contrast the efficacy and safety of the Vizigo sheath with other sheaths in the catheter ablation (CA) for focal atrial tachycardia (FAT). METHODS: A retrospective cohort study was conducted on consecutive patients with CA for FAT from March 2019 to February 2022. Objectives were to assess the impact of the Vizigo sheath on acute and long-term ablation success rates, procedural and fluoroscopy times, and contact force (CF)...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38617758/impact-of-atrial-fibrillation-on-1-year-outcome-in-patients-with-implantable-cardioverter-defibrillator-or-cardiac-resynchronization-therapy-with-defibrillator-results-from-the-german-device-registry
#24
JOURNAL ARTICLE
Sebastian Feickert, Niels Christian Ewertsen, Julia Köbe, Thomas Kleemann, Joachim Jehle, Jochen Senges, Matthias Hochadel, Dietrich Andresen, Christoph Stellbrink, Lars Eckardt, Stefan Spitzer, Johannes Brachmann, Hüseyin Ince, Giuseppe D'Ancona
BACKGROUND: Atrial fibrillation (AF) is a cardiac arrhythmia frequently documented in patients requiring implantable cardioverter defibrillators (ICDs) and/or cardiac resynchronization therapy with defibrillator (CRT-D). Patients with diagnosed AF at the point of ICD or CRT-D implantation may have an impaired follow-up outcome. METHODS: The German DEVICE I-II registry is a nationwide prospective multicentre database of patients implanted with ICD and CRT-D with clinical follow-up data...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38617752/associations-between-waist-circumference-central-obesity-and-the-presence-of-non-valvular-atrial-fibrillation-patients-with-heart-failure
#25
JOURNAL ARTICLE
Bing Wang, Xinglin Yang, Bo Wei, Tingting Ren, Niwen Huang, Carlos Escobar, Philip Y K Pang, Xingde Liu, Haiyan Zhou
BACKGROUND: Reportedly, there is a clear correlation between waist circumference (WC) and atrial fibrillation (AF). However, there is no specific discussion about the relationship between WC and non-valvular AF (NVAF) patients with heart failure. Our main purpose was to study the relationship between WC, central obesity (CO), and NVAF patients with heart failure. METHODS: This is a retrospective cohort study. A total of 3,435 patients with NVAF in the First Affiliated Hospital of Xinjiang Medical University from January 2015 to December 2017 were enrolled...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38614444/natriuretic-peptides-and-prognosis-in-patients-with-type-2-diabetes-mellitus-and-high-risk-for-cardiovascular-events
#26
JOURNAL ARTICLE
Muhammad Shahzeb Khan, James L Januzzi, Yuxi Liu, Jialin Xu, Wayne Shaw, Naveed Sattar, Kenneth W Mahaffey, Bruce Neal, Michael K Hansen, Javed Butler
BACKGROUND: Prognosis of individuals with and without an established heart failure (HF) diagnosis and similarly elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels is not well known. METHODS: CANVAS (Canagliflozin Cardiovascular Assessment Study) trial participants were stratified according to baseline NT-proBNP quartiles and history of HF at baseline. Adjusted event rates per 1000 patient-years follow-up for hospitalizations for HF (HHF), cardiovascular mortality, and kidney events were assessed, and hazard ratios (HR) were calculated using Cox proportional hazard models...
April 11, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38610904/acute-appendicitis-in-the-elderly-a-nationwide-retrospective-analysis
#27
JOURNAL ARTICLE
Malkiely Gal, Paran Maya, Kobo Ofer, Khan Mansoor, Abbou Benyamine, Kessel Boris
Background: Acute appendicitis (AA) in older individuals remains understudied. We aimed to assess AA characteristics in patients older than 60 years and evaluate the impact of comorbidities. Methods: This retrospective study analyzed data from the American National Inpatient Sample between 2016 and 2019 to compare AA characteristics in patients younger and older than 60 years. Results: Of the 538,400 patients included, 27.5% were older than 60 years. Younger patients had a higher appendectomy rate ( p < 0...
April 8, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38610657/retinal-vascular-changes-in-heart-failure-with-preserved-ejection-fraction-using-optical-coherence-tomography-angiography
#28
JOURNAL ARTICLE
Jerremy Weerts, Anne G Raafs, Birgit Sandhoefner, Frank C T van der Heide, Sanne G J Mourmans, Nicolas Wolff, Robert P Finger, Peyman Falahat, Maximilian W M Wintergerst, Vanessa P M van Empel, Stephane R B Heymans
Background: Systemic microvascular regression and dysfunction are considered important underlying mechanisms in heart failure with preserved ejection fraction (HFpEF), but retinal changes are unknown. Methods: This prospective study aimed to investigate whether retinal microvascular and structural parameters assessed using optical coherence tomography angiography (OCT-A) differ between patients with HFpEF and control individuals (i.e., capillary vessel density, thickness of retina layers). We also aimed to assess the associations of retinal parameters with clinical and echocardiographic parameters in HFpEF...
March 25, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608865/association-between-nonalcoholic-fatty-liver-disease-and-left-ventricular-diastolic-dysfunction-a-7-year-retrospective-cohort-study-of-3-496-adults-using-serial-echocardiography
#29
JOURNAL ARTICLE
Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
AIM: Left ventricular diastolic dysfunction (LVDD) has been observed in people with nonalcoholic fatty liver disease (NAFLD) in cross-sectional studies but the causal relationship is unclear. This study aimed to investigate the impact of NAFLD and the fibrotic progression of the disease on the development of LVDD, assessed by serial echocardiography, in a large population over a 7-year longitudinal setting. METHODS: This retrospective cohort study included the data of 3,496 subjects from a medical health check-up program...
April 10, 2024: Diabetes & Metabolism
https://read.qxmd.com/read/38604895/effect-of-sglt2-inhibitors-on-anemia-and-their-possible-clinical-implications
#30
REVIEW
Aleix Cases, Secundino Cigarrán, José Luis Górriz, Julio Nuñez
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes mellitus, heart failure, or chronic kidney disease. Since the first studies with these drugs, an initial increase in hemoglobin/hematocrit levels was observed, which was attributed to an increase in hemoconcentration associated with its diuretic effect, although it was early appearent that these drugs increased erythropoietin levels and erythropoiesis, and improved iron metabolism...
April 10, 2024: Nefrología
https://read.qxmd.com/read/38604447/liver-and-cardiovascular-disease-outcomes-in-metabolic-syndrome-and-diabetic-populations-bi-directional-opportunities-to-multiply-preventive-strategies
#31
JOURNAL ARTICLE
Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Spitz, Amon Asgharpour, Mohammad S Siddiqui, Laurence S Sperling, Arshed A Quyyumi, Anurag Mehta
The incidence and prevalence of metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are rising globally. MetS and T2DM are associated with significant morbidity and mortality, which is partly related to liver and cardiovascular disease. Insulin resistance is central to MetS and T2DM pathophysiology, and drives ectopic fat deposition in the liver, also known as metabolic dysfunction-associated steatotic liver disease (MASLD). MetS and T2DM are not only risk factors for developing MASLD but are also independently associated with disease progression to steatohepatitis, cirrhosis, and hepatocellular carcinoma...
April 9, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38602566/heart-failure-with-preserved-ejection-fraction-diagnosis-risk-assessment-and-treatment
#32
REVIEW
Stephan von Haehling, Birgit Assmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina A Schütt, Rolf Wachter, Paul Christian Schulze, Gerd Hasenfuss, Michael Böhm, Johann Bauersachs
The aetiology of heart failure with preserved ejection fraction (HFpEF) is heterogenous and overlaps with that of several comorbidities like atrial fibrillation, diabetes mellitus, chronic kidney disease, valvular heart disease, iron deficiency, or sarcopenia. The diagnosis of HFpEF involves evaluating cardiac dysfunction through imaging techniques and assessing increased left ventricular filling pressure, which can be measured directly or estimated through various proxies including natriuretic peptides. To better narrow down the differential diagnosis of HFpEF, European and American heart failure guidelines advocate the use of different algorithms including comorbidities that require diagnosis and rigorous treatment during the evaluation process...
April 11, 2024: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://read.qxmd.com/read/38602004/-sglt2-inhibitors-also-in-frail-older-adults
#33
REVIEW
Dorianne M van Bruggen, David R M Jansen, Eveline P van Poelgeest
Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) have gained prominence in the treatment of diabetes mellitus type 2, heart failure, and chronic kidney disease. However, concerns arise for frail older adults, given their underrepresentation in trials and heightened susceptibility to adverse drug events. This review summarizes the clinical effects of SGLT2 inhibitors in older adults with frailty. SGLT2 inhibitors seem to exhibit consistent cardiovascular benefits irrespective of age. As such, these drugs can be beneficial for older adults with 'cardiovascular frailty': in other words, cardiovascular multimorbidity...
April 11, 2024: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/38597756/chronic-heart-failure-in-patients-hospitalized-in-2002-and-2021-comparative-analysis-of-prevalence-clinical-course-and-drug-therapy
#34
JOURNAL ARTICLE
A A Garganeeva, O V Tukish, K N Vitt, Yu V Mareev, E A Kuzheleva, V V Ryabov, M Yu Kondratiev, E E Syromyatnikova, B B Dorzhieva, V Yu Mareev
AIM: Comparative analysis of the prevalence of chronic heart failure (CHF), clinical and medical history data, and drug therapy of patients admitted to a cardiology hospital in 2002 and 2021. MATERIAL AND METHODS: The study analyzed the medical records of patients with a confirmed diagnosis of CHF who were admitted in 2002 (n=210) and 2021 (n=381) to a specialized cardiology hospital. RESULTS: According to medical records of 2021, the proportion of patients with a confirmed diagnosis of CHF (87...
March 31, 2024: Kardiologiia
https://read.qxmd.com/read/38596912/stage-b-heart-failure-is-ubiquitous-in-emergency-patients-with-asymptomatic-hypertension
#35
JOURNAL ARTICLE
Kimberly Souffront, Bret P Nelson, Megan Lukas, Hans Reyes Garay, Lauren Gordon, Thalia Matos, Isabella Hanesworth, Rebecca Mantel, Claire Shubeck, Cassidy Bernstein, George T Loo, Lynne D Richardson
INTRODUCTION: Hypertension is the leading risk factor for morbidity and mortality throughout the world and is pervasive in United States emergency departments (ED). This study documents the point prevalence of subclinical heart disease in emergency patients with asymptomatic hypertension. METHOD: This was a prospective observational study of ED patients with asymptomatic hypertension conducted at two urban academic EDs that belong to an eight-hospital healthcare organization in New York...
March 2024: Western Journal of Emergency Medicine
https://read.qxmd.com/read/38596692/molecular-mechanisms-of-metabolic-dysregulation-in-diabetic-cardiomyopathy
#36
REVIEW
Yue Zeng, Yilang Li, Wenyue Jiang, Ning Hou
Diabetic cardiomyopathy (DCM), one of the most serious complications of diabetes mellitus, has become recognized as a cardiometabolic disease. In normoxic conditions, the majority of the ATP production (>95%) required for heart beating comes from mitochondrial oxidative phosphorylation of fatty acids (FAs) and glucose, with the remaining portion coming from a variety of sources, including fructose, lactate, ketone bodies (KB) and branched chain amino acids (BCAA). Increased FA intake and decreased utilization of glucose and lactic acid were observed in the diabetic hearts of animal models and diabetic patients...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38595874/mycobacterium-porcinum-disseminated-infection-in-non-severely-immunocompromised-host
#37
Shuva Shah, Kashaf Zaidi, Will Onyia
Mycobacterium porcinum  is a nontuberculous mycobacteria (NTM) recently identified to cause human infection. Correct speciation of NTMs can be difficult and result in misdiagnosis and delayed treatment. Because of the paucity of the literature, there is a lack of awareness of the possibility of serious infections caused by  M. porcinum . Although severe infections tend to occur in individuals with certain risk factors, the primary being an immunocompromised state, our case illustrates that it can also be possible in non-severely immunocompromised individuals...
March 2024: Curēus
https://read.qxmd.com/read/38593202/the-role-of-exercise-training-on-cardiovascular-risk-factors-and-heart-disease-in-patients-with-chronic-kidney-disease-g3-g5-and-g5d-a-clinical-consensus-statement-of-the-european-association-of-preventive-cardiology-eapc-of-the-esc-and-the-european-association
#38
JOURNAL ARTICLE
Evangelia Kouidi, Henner Hanssen, Kirsten Anding-Rost, Adamasco Cupisti, Asterios Deligiannis, Clemens Grupp, Pelagia Koufaki, Paul Leeson, Eva Segura-Orti, Amaryllis Van Craenenbroeck, Emeline Van Craenenbroeck, Naomi Clyne, Halle Martin
Cardiovascular (CV) morbidity and mortality is high in patients with chronic kidney disease (CKD). Most patients reveal a high prevalence of CV risk factors such as diabetes or arterial hypertension and many have manifest cardiovascular disease (CVD), such as coronary artery disease and chronic heart failure with an increased risk of clinical events including sudden cardiac death. Diabetes mellitus and hypertension contribute to the development of CKD and the prevalence of CKD is in the range of 20%-65% in diabetic and 30%-50% in hypertensive patients...
April 9, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38593150/spatial-characteristics-of-non-communicable-diseases-and-their-associations-to-social-conditions-in-a-large-urban-cohort-in-germany-results-from-the-hamburg-city-health-study
#39
JOURNAL ARTICLE
Valerie Andrees, Ramona Bei der Kellen, Matthias Augustin, Jürgen Gallinat, Volker Harth, Hanno Hoven, Simone Kühn, Anne Lautenbach, Christina Magnussen, Nicole Mohr, Raphael Twerenbold, Ines Schäfer, Benjamin Waschki, Birgit-Christiane Zyriax, Jobst Augustin
BACKGROUND: Non-communicable diseases (NCDs) are responsible for many deaths. They are associated with several modifiable and metabolic risk factors and are therefore prone to significant regional variations on different scales. However, only few intra-urban studies examined spatial variation in NCDs and its association with social circumstances, especially in Germany. Thus, the present study aimed to identify associations of personal risk factors and local social conditions with NCDs in a large German city...
2024: PloS One
https://read.qxmd.com/read/38592232/effects-of-sglt2-inhibitors-with-and-without-metformin-in-high-risk-treatment-na%C3%A3-ve-patients-with-diabetes
#40
JOURNAL ARTICLE
Chen-Yu Huang, Jen-Kuang Lee
Background: Contemporary evidence supports the cardiovascular and renal benefits of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in patients with diabetes. While metformin has traditionally been recommended as a first-line treatment, its exact role in improving cardiovascular outcomes remains uncertain. This study aims to evaluate the impact of combination therapy with metformin on the cardiovascular and renal outcomes in high-risk, treatment-naïve diabetic patients who have undergone SGLT2i therapy...
February 28, 2024: Journal of Clinical Medicine
keyword
keyword
168947
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.